![J. Michael Schafer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
J. Michael Schafer
Keine laufenden Positionen mehr
Profil
J.
Michael Schafer worked as a Director at Wellkeeper, Inc. and Essen Instruments, Inc. He was a Vice President at Sunpharm Corp.
and a General Partner and Principal at Tullis Health Investors, Inc. He was also a General Partner at Woodlands Venture Partners LP.
Schafer's education includes an undergraduate degree from Davidson College and an MBA from the University of Michigan.
Ehemalige bekannte Positionen von J. Michael Schafer
Unternehmen | Position | Ende |
---|---|---|
New Mexico Community Capital
![]() New Mexico Community Capital Investment ManagersFinance New Mexico Community Capital (NMCC) is a venture capital firm founded in 2004. The firm is headquartered in Albuquerque, New Mexico. | Private Equity Investor | 02.01.2022 |
Tullis Health Investors, Inc.
![]() Tullis Health Investors, Inc. Investment ManagersFinance Tullis Health Investor Inc (Tullis Health) is a private equity and venture capital firm founded in 1986 by Jim Tullis. The firm is headquartered in Palm Beach, Florida. | Private Equity Investor | 02.01.2002 |
Sunpharm Corp.
![]() Sunpharm Corp. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sunpharm Corp. is a company that develops small molecule pharmaceutical products. The company is based in Jacksonville, FL. The company was founded by Harry Z. Rosengart. Sunpharm was acquired by GelTex Pharmaceuticals, Inc. on November 17, 1999 for $12.16 million. | Private Equity Investor | 02.01.1998 |
Woodlands Venture Partners LP | Private Equity Investor | 02.01.1992 |
Essen Instruments, Inc.
![]() Essen Instruments, Inc. Electronic Equipment/InstrumentsElectronic Technology Essen Instruments, Inc. engages in the development and manufacture of cell and bead based screening solutions. It offers phenotypic drug discovery, antibody discovery and in vitro toxicity testing. The firm’s proprietary technologies, instrumentation, assays and software products address the pervasive need to provide turnkey solutions that increase productivity in pharmaceutical, biotechnology and life science research. The company’s products are used in biologics discovery, small molecules, in vitro tox and cellular research antibody applications. The company was founded by R. Terry Dunlay, Larry A. Sklar, and Bruce S. Edwards in 2006 and is headquartered in Ann Arbor, MI. | Direktor/Vorstandsmitglied | - |
Ausbildung von J. Michael Schafer
Davidson College | Undergraduate Degree |
University of Michigan | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
Sunpharm Corp.
![]() Sunpharm Corp. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sunpharm Corp. is a company that develops small molecule pharmaceutical products. The company is based in Jacksonville, FL. The company was founded by Harry Z. Rosengart. Sunpharm was acquired by GelTex Pharmaceuticals, Inc. on November 17, 1999 for $12.16 million. | Health Technology |
Wellkeeper, Inc.
![]() Wellkeeper, Inc. Packaged SoftwareTechnology Services Wellkeeper, Inc. engages in the provision of remote monitoring solutions for independent oil and gas operators. It offers alarm support, tank monitoring, equipment monitoring, and remote pump control. The company was founded by Randy Krall in 2001 and is headquartered in Albuquerque, NM. | Technology Services |
Tullis Health Investors, Inc.
![]() Tullis Health Investors, Inc. Investment ManagersFinance Tullis Health Investor Inc (Tullis Health) is a private equity and venture capital firm founded in 1986 by Jim Tullis. The firm is headquartered in Palm Beach, Florida. | Finance |
Essen Instruments, Inc.
![]() Essen Instruments, Inc. Electronic Equipment/InstrumentsElectronic Technology Essen Instruments, Inc. engages in the development and manufacture of cell and bead based screening solutions. It offers phenotypic drug discovery, antibody discovery and in vitro toxicity testing. The firm’s proprietary technologies, instrumentation, assays and software products address the pervasive need to provide turnkey solutions that increase productivity in pharmaceutical, biotechnology and life science research. The company’s products are used in biologics discovery, small molecules, in vitro tox and cellular research antibody applications. The company was founded by R. Terry Dunlay, Larry A. Sklar, and Bruce S. Edwards in 2006 and is headquartered in Ann Arbor, MI. | Electronic Technology |
New Mexico Community Capital
![]() New Mexico Community Capital Investment ManagersFinance New Mexico Community Capital (NMCC) is a venture capital firm founded in 2004. The firm is headquartered in Albuquerque, New Mexico. | Finance |
Woodlands Venture Partners LP |